Antibody–drug conjugates: from efficacy testing to bioassay evaluation in modern drug development

Christine Koehler, Ulrike Herbrand, Marie-Soleil Piche, Julia Schueler

Open source

DOI
10.1016/j.drudis.2026.104636
Published
2026-05
Container
Drug Discovery Today
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.drudis.2026.104636,
  title = {Antibody–drug conjugates: from efficacy testing to bioassay evaluation in modern drug development},
  author = {Christine Koehler and Ulrike Herbrand and Marie-Soleil Piche and Julia Schueler},
  year = {2026},
  journal = {Drug Discovery Today},
  doi = {10.1016/j.drudis.2026.104636},
  url = {https://doi.org/10.1016/j.drudis.2026.104636}
}

RIS

TY  - JOUR
TI  - Antibody–drug conjugates: from efficacy testing to bioassay evaluation in modern drug development
AU  - Christine Koehler
AU  - Ulrike Herbrand
AU  - Marie-Soleil Piche
AU  - Julia Schueler
PY  - 2026
JO  - Drug Discovery Today
DO  - 10.1016/j.drudis.2026.104636
UR  - https://doi.org/10.1016/j.drudis.2026.104636
ER  - 

APA

Koehler, C., Herbrand, U., Piche, M., & Schueler, J. (2026). Antibody–drug conjugates: from efficacy testing to bioassay evaluation in modern drug development. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2026.104636

Source records